Literature DB >> 27402382

Super-spreading events of MERS-CoV infection.

David S Hui1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27402382      PMCID: PMC7136991          DOI: 10.1016/S0140-6736(16)30828-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in September, 2012, from a 68-year-old man who had died of severe pneumonia and multiorgan failure in Saudi Arabia in June, 2012. Since then, MERS-CoV infection has spread to 27 countries, including South Korea, where 186 cases had been confirmed within 2 months following the return of a Korean businessman (Patient 1) who had visited four countries in the Middle East between April 18 and May 3, 2015. This major outbreak in South Korea is characterised by five super-spreading events in hospital settings, of which two were related—one at Pyeongtaek St Mary's Hospital (Pyeongtaek; by Patient 1) and one at Samsung Medical Center (Seoul; by Patient 14). During Patient 1's stay at Pyeongtaek St Mary's Hospital on May 15–17, 2015, he had infected 36 patients, including Patient 14, who was staying on the same floor. Both Patient 1 and Patient 14 had sought medical attention at different health-care facilities before being treated at the Samsung Medical Center on May 17–20 (Patient 1) and May 27–29 (Patient 14), around day 7 of their illness when they were highly infectious. However, it was Patient 14 who had led to the major nosocomial outbreak at the Samsung Medical Center. Patient 1 had initially presented to the emergency room on May 17, 2015, when the hospital was full; he was admitted and isolated immediately on May 18, 2015, after his travel history to the Middle East was ascertained by a medical officer, without causing any nosocomial outbreak. In The Lancet, Sun Young Cho and colleagues report results from their comprehensive retrospective investigation of the MERS-CoV super-spreading event at the Samsung Medical Center emergency room, including a review of closed-circuit security video footage and electronic medical records. This nosocomial outbreak was most intriguing, with 82 people (33 patients, eight health-care workers, and 41 visitors) being infected following exposure to Patient 14 on May 27–29 in the emergency room. Patients staying in the same zone as Patient 14 had the highest attack rate (20% [23 of 117 patients]), compared with 5% (three of 58) in those with brief exposure to Patient 14 at the registration area or the radiology suite of the emergency room, and 1% (four of 500) in other patients who stayed in different zones. The median incubation period of patients who stayed in the same zone as Patient 14 was shorter than that in patients who stayed in different zones (5 days [IQR 4–8] vs 11 days [6-12]; p<0·0001). No cases were documented in patients and visitors who had visited the emergency room on May 29 and were exposed only to potentially contaminated environment without direct contact with Patient 14. The data suggest that the location (and hence the timing) of exposure to Patient 14 was an important factor in determining the attack rate and incubation period. Several other predisposing factors to this super-spreading event included failure to implement strict isolation of patients and quarantine of contacts at the first outbreak hospital (Pyeongtaek St Mary's Hospital),3, 4 poor communication and knowledge of patient movement between hospitals, overcrowding in the emergency room, inadequate ventilation with only three air changes per h, and limited availability of isolation rooms in the emergency room. At least six air changes per h in existing hospital facilities are needed to reduce room contamination in the management of acute respiratory infections, whereas 12 air changes per h are recommended for new or renovated facilities, especially when managing patients receiving mechanical ventilation and during aerosol-generating procedures. Failure in infection control and prevention in health-care facilities has resulted in large numbers of secondary cases of MERS-CoV infection involving health-care workers, existing patients, and visitors in Saudi Arabia7, 8 and several other countries in the past few years.5, 9, 10 Common risk factors include exposure to contaminated and overcrowded health-care facilities, poor compliance with appropriate personal protection equipment when assessing patients with febrile respiratory illness, application of potential aerosol-generating procedures (eg, resuscitation, continuous positive airway pressure, nebulised drugs), and lack of proper isolation room facilities.5, 7, 8, 9, 10 The customs of patients seeking care at different health-care facilities (so-called doctor shopping), as in the cases of Patients 1 and 14, and having friends and family members to stay with patients as caregivers at already overcrowded health-care facilities are unique factors in South Korea. Although no aerosol-generating procedures were performed (with the exception of Patient 14 receiving supplemental oxygen at 2–5 L per min during his stay at the emergency room), the role of such procedures, environmental contamination, and asymptomatic carriers in disease transmission would require further investigation in future major nosocomial outbreaks of MERS-CoV infection. Good compliance with appropriate personal protection equipment by health-care workers when managing patients with suspected and confirmed MERS-CoV infection, early diagnosis, prompt isolation of infected patients, and improvement of ventilation in health-care facilities are important measures to prevent nosocomial outbreaks.
  9 in total

1.  Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation.

Authors:  B Hijawi; M Abdallat; A Sayaydeh; S Alqasrawi; A Haddadin; N Jaarour; S Alsheikh; T Alsanouri
Journal:  East Mediterr Health J       Date:  2013       Impact factor: 1.628

2.  2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.

Authors:  Ikwo K Oboho; Sara M Tomczyk; Ahmad M Al-Asmari; Ayman A Banjar; Hani Al-Mugti; Muhannad S Aloraini; Khulud Z Alkhaldi; Emad L Almohammadi; Basem M Alraddadi; Susan I Gerber; David L Swerdlow; John T Watson; Tariq A Madani
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

3.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

4.  Hospital outbreak of Middle East respiratory syndrome coronavirus.

Authors:  Abdullah Assiri; Allison McGeer; Trish M Perl; Connie S Price; Abdullah A Al Rabeeah; Derek A T Cummings; Zaki N Alabdullatif; Maher Assad; Abdulmohsen Almulhim; Hatem Makhdoom; Hossam Madani; Rafat Alhakeem; Jaffar A Al-Tawfiq; Matthew Cotten; Simon J Watson; Paul Kellam; Alimuddin I Zumla; Ziad A Memish
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

5.  Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015.

Authors: 
Journal:  Osong Public Health Res Perspect       Date:  2015-09-05

6.  Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital.

Authors:  Kyung Min Kim; Moran Ki; Sung-Il Cho; Minki Sung; Jin Kwan Hong; Hae-Kwan Cheong; Jong-Hun Kim; Sang-Eun Lee; Changhwan Lee; Keon-Joo Lee; Yong-Shik Park; Seung Woo Kim; Bo Youl Choi
Journal:  Epidemiol Health       Date:  2015-09-17

7.  Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi.

Authors:  Jennifer C Hunter; Duc Nguyen; Bashir Aden; Zyad Al Bandar; Wafa Al Dhaheri; Kheir Abu Elkheir; Ahmed Khudair; Mariam Al Mulla; Feda El Saleh; Hala Imambaccus; Nawal Al Kaabi; Farrukh Amin Sheikh; Jurgen Sasse; Andrew Turner; Laila Abdel Wareth; Stefan Weber; Asma Al Ameri; Wesal Abu Amer; Negar N Alami; Sudhir Bunga; Lia M Haynes; Aron J Hall; Alexander J Kallen; David Kuhar; Huong Pham; Kimberly Pringle; Suxiang Tong; Brett L Whitaker; Susan I Gerber; Farida Ismail Al Hosani
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

8.  Infection control and MERS-CoV in health-care workers.

Authors:  Alimuddin Zumla; David S Hui
Journal:  Lancet       Date:  2014-05-20       Impact factor: 79.321

9.  MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study.

Authors:  Sun Young Cho; Ji-Man Kang; Young Eun Ha; Ga Eun Park; Ji Yeon Lee; Jae-Hoon Ko; Ji Yong Lee; Jong Min Kim; Cheol-In Kang; Ik Joon Jo; Jae Geum Ryu; Jong Rim Choi; Seonwoo Kim; Hee Jae Huh; Chang-Seok Ki; Eun-Suk Kang; Kyong Ran Peck; Hun-Jong Dhong; Jae-Hoon Song; Doo Ryeon Chung; Yae-Jean Kim
Journal:  Lancet       Date:  2016-07-09       Impact factor: 79.321

  9 in total
  11 in total

1.  Coronavirus Entry Inhibitors.

Authors:  Qiaoshuai Lan; Shuai Xia; Lu Lu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  MERS-CoV: Understanding the Latest Human Coronavirus Threat.

Authors:  Aasiyah Chafekar; Burtram C Fielding
Journal:  Viruses       Date:  2018-02-24       Impact factor: 5.048

3.  Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.

Authors:  John Kinsman; John Angrén; Fredrik Elgh; Maria Furberg; Paola A Mosquera; Laura Otero-García; René Snacken; Tarik Derrough; Paloma Carrillo Santisteve; Massimo Ciotti; Svetla Tsolova
Journal:  BMC Health Serv Res       Date:  2018-07-06       Impact factor: 2.655

4.  Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19.

Authors:  Pablo M Beldomenico
Journal:  Int J Infect Dis       Date:  2020-05-11       Impact factor: 3.623

5.  An updated roadmap for MERS-CoV research and product development: focus on diagnostics.

Authors:  Cassandra Kelly-Cirino; Laura T Mazzola; Arlene Chua; Christopher J Oxenford; Maria D Van Kerkhove
Journal:  BMJ Glob Health       Date:  2019-02-01

Review 6.  Escherichia coli, cattle and the propagation of disease.

Authors:  Richard A Stein; David E Katz
Journal:  FEMS Microbiol Lett       Date:  2017-03-01       Impact factor: 2.742

7.  Recommendations on cardiopulmonary resuscitation strategy and procedure for novel coronavirus pneumonia.

Authors:  Wei Song; Yuanshui Liu; Yanhong Ouyang; Wenteng Chen; Min Li; Shuming Xianyu; Shengyang Yi
Journal:  Resuscitation       Date:  2020-04-07       Impact factor: 5.262

8.  Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).

Authors:  Alimuddin Zumla; Abdulaziz N Alagaili; Matthew Cotten; Esam I Azhar
Journal:  BMC Med       Date:  2016-09-07       Impact factor: 8.775

9.  Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.

Authors:  Daisuke Yoneoka; Yuta Tanoue; Takayuki Kawashima; Shuhei Nomura; Shoi Shi; Akifumi Eguchi; Keisuke Ejima; Toshibumi Taniguchi; Haruka Sakamoto; Hiroyuki Kunishima; Stuart Gilmour; Hiroshi Nishiura; Hiroaki Miyata
Journal:  Lancet Reg Health West Pac       Date:  2020-10-10

10.  Effectiveness of Intervention Strategies on MERS-CoV Transmission Dynamics in South Korea, 2015: Simulations on the Network Based on the Real-World Contact Data.

Authors:  Yunhwan Kim; Hohyung Ryu; Sunmi Lee
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.